Skip to main content
. 2023 Sep;75(5):885–958. doi: 10.1124/pharmrev.122.000600

TABLE 12.

Additional and less potent inhibitors of AEA cellular uptake relative to inhibition of AEA degradation (by FAAH) or intracellular transport (by FABP5)

Compound AEA Cellular Uptake Inhibition
IC50 (µM) Cell Type FAAH
IC50 Value (µM)
FABP5
Ki Value (µM)
Inline graphicBMS309403
Sulsky et al., 2007; Kaczocha et al., 2009; Berger et al., 2012; Kaczocha et al., 2012; Nicolussi et al., 2014a
∼100
[57% inh.]
>100
[48% inh.]
24.7
>100
[30% inh.]
N18TG2
COS7-FAAH-eGFP
U937
HMC-1*
>100
>100
0.35
0.75
0.89
Inline graphicSBFI-26 (RT26)
Berger et al., 2012: Zhou et al., 2019a
∼20
[40% inh.]
HeLaa >50 0.9

aCells lacking FAAH-activity.